Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 

Investorideas podcasts on iTunes, Google Play Music and    Bitcoin and Blockchain Stocks    Play by Play – the latest sports headlines and sports stock news


Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Global #Cannabis Testing Market Opportunity & Analysis, Featuring Thermo Fisher Scientific, Sigma-Aldrich, Agilent Technologies, Perkinelemer, Steep Hill Halent Laboratories & Eli Lilly


DUBLIN - May 22, 2017 ( Newswire) Research and Markets has announced the addition of the "Global Cannabis Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report to their offering.

The global cannabis testing market is expected to grow with the CAGR of approximately 11.7% during the forecast period 2016-2023

Increasing demand for LIMS systems in cannabis testing is one of the major driving factors for the market.

LIMS is an effective platform for marijuana testing services in order to track internal processes, instrument integration, data collection and reporting capabilities. Lack of qualified technicians has forced governments to set up laboratory automation systems to do laboratory testing with the timely and cost-effective manner. It not only enhances the productivity and accuracy but it is also required to manage information effectively. A cloud LIMS system is extremely useful for medical marijuana testing labs. LIMS system is easy to use for the person who is handling cannabis testing. Expansion of cannabis testing laboratories, legalization on the utilization of cannabis in medicine and increasing drug driven accidents are also driving the market growth. Lack of industry standards are acting as a major restraining factor for the market.

On the other hand, rising funding for cannabis industry and increasing demand in developing countries are creating good opportunity for the market. However, lack of skilled professionals and high initial investment are the crucial challenges for the market.

Geographically, North America held major share for cannabis testing market, in terms of revenue in 2016 due to increasing demand for cannabis testing laboratories in California and the presence of major players such as Thermo Fisher Scientific (U.S.), Sigma-Aldrich (U.S.) in the region. The major players included in the report Are Thermo Fisher Scientific, Sigma-Aldrich, Agilent Technologies Inc., Perkinelemer Inc., Steep Hill Halent Laboratories Inc. and Eli Lilly etc. Product launches, mergers & acquisitions etc. are some crucial strategies adopted by the major players to gain competitive advantage.

The global cannabis testing market is segmented into type, products & software and end-user. The type segment is further classified into terpene profiling, heavy metal testing, microbial analysis, genetic testing, residual solvent screening, potency testing and pesticide screening.

According to products & software segment, the product segment comprises analytical instruments and consumables. The end-user is further classified into laboratories and research institutions. Laboratories held major share in the end-user segment in 2015 due to increasing demand for cannabis testing software and products in laboratories. Particularly in the U.S., there has been significant rise witnessed in cannabis testing laboratories due to legalization on the utilization of cannabis in medicine, expansion of cannabis testing laboratories, and increasing availability of technologically developed analytical instruments and software i.e. LIMS for the cannabis industry.

Market Determinants

Market Drivers

  • Rising Demand for Lims Systems in Cannabis Testing
  • Expansion of Cannabis Testing Laboratories
  • Legalization On the Utilization of Cannabis in Medicine
  • Creating Awareness Through Programs
  • Increasing Drug Abuse Related Accidents

Market Restraints

  • Lack of Industry Standards for Cannabis Testing
  • High Cost of Analytical Instruments

Market Opportunities

  • Increasing Demand in Developing Countries
  • Rising Funding for the Cannabis Industry

Market Challenges

  • Lack of Skilled Professionals
  • High Initial Investment

Key Topics Covered:

  1. Introduction
  2. Market Overview
  3. Market Determinants
  4. Market Segmentation
  5. Competitive Landscape
  6. Geographical Analysis
  7. Company Profiles
    • Accelerated Technology Laboratories, Inc.
    • Agilent Technologies Inc.
    • Anresco Laboratories
    • CMT Laboratories Llc.
    • Digipath, Inc.
    • Eli Lilly
    • Perkinelmer, Inc.
    • Pharmlabs Llc
    • Restek Corporation
    • SC Laboratories, Inc.
    • Shimadzu Corporation
    • Sigma-Aldrich
    • Steep Hill Halent Laboratories, Inc.
    • Thermo Fisher Scientific
    • Waters Corporation

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Laboratory Testing

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.